The following information is intended as a resource for journalists only and was factually correct at the time it was issued.

Follow AbbVie UK

Tags

Latest news

AbbVie Appoints New General Manager in U.K.

Press releases   •   Jul 19, 2019 13:03 BST

Todd Manning has been named General Manager, AbbVie U.K. This change will be effective 1st September 2019. Todd moves to the UK from his current position within the company as General Manager, AbbVie Ireland.

AbbVie Receives CHMP Positive Opinion for SKYRIZI™ ▼ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis in adults

Press releases   •   Mar 01, 2019 12:13 GMT

CHMP positive opinion, supported by data from the pivotal Phase 3 program evaluating more than 2,000 patients with moderate to severe plaque psoriasis, will now be reviewed by the European Commission1-3

HUMIRA® (adalimumab) 80 mg/0.8 mL Presentation intended as an Alternative Option for Therapy Induction and Maintenance Therapy is Now Available

Press releases   •   Dec 03, 2018 09:25 GMT

• HUMIRA citrate-free 80 mg/0.8 mL formulation reduces the number of injections required to initiate HUMIRA therapy by half • Convenient 80 mg every other week dosing for patients that require dose escalation

Efforts to Improve Patient Safety and Care Recognised in National Health Awards

Efforts to Improve Patient Safety and Care Recognised in National Health Awards

Press releases   •   Nov 20, 2018 15:27 GMT

South Tees NHS Foundation Trust, Lymphoma Action and Arthur’s Choice win 2018 AbbVie Big Ideas for Better Health Awards

AbbVie announces the introduction of an interim commercial offer to the NHS for HUMIRA® (adalimumab) from 1st November 2018

Press releases   •   Oct 18, 2018 14:33 BST

AbbVie announces the introduction of an interim commercial offer to the NHS for HUMIRA® (adalimumab) from 1st November 2018